(TCAF) T. Rowe Price - Overview
ETF Category: Large Blend | Exchange: NYSE ARCA (USA) | Market Cap: 6.044m USD | Total Return: 14.8% in 12m
Etf
Stocks, Large Companies, U.S
Total Rating 26
Safety 49
Buy Signal -0.02
Risk 5d forecast
Volatility19.1%
Rel. Tail Risk4.66%
Reward TTM
Sharpe Ratio0.43
Alpha-5.50
Character TTM
Beta0.875
Beta Downside0.789
Drawdowns 3y
Max DD16.37%
CAGR/Max DD0.80
Description: TCAF T. Rowe Price
TCAF is an actively managed ETF primarily investing in US large-cap equity securities. It allocates at least 80% of its net assets to stocks.
The fund may concentrate investments in sectors such as information technology and healthcare. The information technology sector is characterized by rapid innovation and high growth potential. The healthcare sector is often considered defensive due to consistent demand for its services.
TCAF is a non-diversified fund, meaning it can hold a more concentrated portfolio than diversified funds. This approach can lead to higher volatility. For more detailed analysis, consider exploring ValueRay.
- Equity market performance directly impacts fund asset values
- Large-cap U.S. company stock performance dictates returns
- Information technology sector concentration creates risk/reward
- Healthcare sector performance significantly influences fund value
- Non-diversified strategy amplifies stock-specific risk
What is the price of TCAF shares?
As of April 04, 2026, the stock is trading at USD 35.59 with a total of 936,312 shares traded.
Over the past week, the price has changed by +3.88%, over one month by -4.01%, over three months by -6.34% and over the past year by +14.84%.
Over the past week, the price has changed by +3.88%, over one month by -4.01%, over three months by -6.34% and over the past year by +14.84%.
Is TCAF a buy, sell or hold?
T. Rowe Price has no consensus analysts rating.
What are the forecasts/targets for the TCAF price?
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
External Resources